ES2054841T3 - Vector viral y adn recombinante que codifica para una o unas proteinas de estructura (ha, f y/o np), de un morbilivirus. - Google Patents

Vector viral y adn recombinante que codifica para una o unas proteinas de estructura (ha, f y/o np), de un morbilivirus.

Info

Publication number
ES2054841T3
ES2054841T3 ES88401750T ES88401750T ES2054841T3 ES 2054841 T3 ES2054841 T3 ES 2054841T3 ES 88401750 T ES88401750 T ES 88401750T ES 88401750 T ES88401750 T ES 88401750T ES 2054841 T3 ES2054841 T3 ES 2054841T3
Authority
ES
Spain
Prior art keywords
morbilivirus
recombinant dna
viral vector
dna coding
structure proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88401750T
Other languages
English (en)
Inventor
Robert Drillien
Daniele Spehner
Fabian Wild
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of ES2054841T3 publication Critical patent/ES2054841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

POXVIRUS RECOMBINANTE QUE EXPRESA UNA O MAS PROTEINAS DE ESTRUCTURA HA, F Y/O NP DE UN MORBILLIVIRUS, VACUNA COMPUESTA DE ESTE POXVIRUS O DE LAS PROTEINAS DEL MORBILLIVIRUS QUE EL SINTETIZA.
ES88401750T 1987-07-07 1988-07-05 Vector viral y adn recombinante que codifica para una o unas proteinas de estructura (ha, f y/o np), de un morbilivirus. Expired - Lifetime ES2054841T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8709629A FR2617715B1 (fr) 1987-07-07 1987-07-07 Vecteur viral et adn recombinant codant pour une ou des proteines de surface (ha et/ou f) d'un morbillivirus, culture cellulaire infectee, proteines obtenues, vaccin et anticorps obtenus

Publications (1)

Publication Number Publication Date
ES2054841T3 true ES2054841T3 (es) 1994-08-16

Family

ID=9352955

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88401750T Expired - Lifetime ES2054841T3 (es) 1987-07-07 1988-07-05 Vector viral y adn recombinante que codifica para una o unas proteinas de estructura (ha, f y/o np), de un morbilivirus.

Country Status (7)

Country Link
EP (1) EP0305229B1 (es)
JP (1) JP2819023B2 (es)
AT (1) ATE107695T1 (es)
CA (1) CA1341331C (es)
DE (1) DE3850323T2 (es)
ES (1) ES2054841T3 (es)
FR (1) FR2617715B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01218590A (ja) * 1988-02-29 1989-08-31 Toa Nenryo Kogyo Kk 組換ワクチニアウイルスを用いたリンダペスト（牛疫）ウイルスワクチン
IE71643B1 (en) * 1990-11-20 1997-02-26 Virogenetics Corp A recombinant poxviral vaccine for canine distemper
WO1998052603A2 (en) * 1997-05-23 1998-11-26 Schweiz. Serum- & Impfinstitut Bern An influenza enveloped dna vaccine
CN1089370C (zh) * 1994-12-08 2002-08-21 中国预防医学科学研究院病毒学研究所 表达麻疹病毒l4株血凝素及融合蛋白基因的重组痘苗病毒
FR2766091A1 (fr) 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607518B1 (fr) * 1986-12-01 1989-10-20 Transgene Sa Vecteur viral et adn recombinant codant pour la proteine p25 du virus agent causal du s.i.d.a., culture cellulaire infectee, proteine obtenue, vaccin et anticorps obtenus

Also Published As

Publication number Publication date
EP0305229B1 (fr) 1994-06-22
DE3850323T2 (de) 1994-12-22
ATE107695T1 (de) 1994-07-15
CA1341331C (fr) 2002-01-01
DE3850323D1 (de) 1994-07-28
FR2617715A1 (fr) 1989-01-13
FR2617715B1 (fr) 1990-08-31
JPH01157379A (ja) 1989-06-20
EP0305229A1 (fr) 1989-03-01
JP2819023B2 (ja) 1998-10-30

Similar Documents

Publication Publication Date Title
DE68927025D1 (de) HIV-2-Virusvarianten
ES2078907T3 (es) Metodo para radiomarcar proteinas.
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
ES2099273T3 (es) Comprimidos de verapamil de liberacion controlada.
ES2054878T3 (es) Expresion de la proapolipoproteina a-i humana.
DE10399031I1 (de) Rekombinante Viren.
ATE33558T1 (de) Stabilisierung von influenzavirusimpfstoffen.
ES2056817T3 (es) Transformacion de trichoderma.
DK0670899T3 (da) Varmeshockproteiner og behandling af tumorer
DK366483D0 (da) Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmade til fremstilling af samme samt fremgangsmade til fremstilling af human preprorelaxin eller en underenhed deraf
AR248045A1 (es) Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia
DK606285A (da) Vaccine mod rabies samt fremgangsmaade til fremstilling deraf
DE3789400D1 (de) Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper.
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
NO883834L (no) Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ES2070846T3 (es) Arn-virus sin reversion.
DK498387A (da) Virus-dna-sekvens
DE3850323D1 (de) Virusvektor und Rekombinante DNS, die ein oder mehrere strukturelle Proteine (HA,F und/oder NP) eines Morbillivirus Kodieren.
DK76688A (da) Vaccine indeholdende f-proteinet fra aids-virus
ATE107361T1 (de) Gen des hüllproteins des gurkenmosaikvirus.
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 305229

Country of ref document: ES